Pharmacoeconomic study of active psoriatic arthritis treatment
Objective: to conduct a clinical and economic analysis of the therapy for adult patients with psoriatic arthritis (PsA) using netakimab, a Russian interleukin-17 inhibitor, in comparison with other biological (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs), available o...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
IRBIS LLC
2025-02-01
|
| Serija: | Фармакоэкономика |
| Teme: | |
| Online dostop: | https://www.pharmacoeconomics.ru/jour/article/view/1139 |
| Oznake: |
Brez oznak, prvi označite!
|